Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 6, 2010, Pages 505-510

  Kelishadi, Roya ^a   Hashemipour, Mahin ^b   Adeli, Khosrow ^c   Tavakoli, Naser ^d   Movahedian Attar, Ahmad ^d   Shapouri, Javad ^b   Poursafa, Parinaz ^e   Rouzbahani, Akbar ^f  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Science and Research University   (Iran)

^f SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; INSULIN; LEPTIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; ZINC;

ARTICLE; BLOOD PRESSURE; BODY MASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

BIOLOGICAL MARKERS; CHILD; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PLACEBOS; PUBERTY; ZINC;

EID: 78649943138     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2010.0020     Document Type: Article

References (32)

1. Milei J, Ottaviani G, Lavezzi AM, Grana DR, Stella I, Mat-turri L, Perinatal and infant early atherosclerotic coronary lesions. Can J Cardiol 2008;24:137-141.
2. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease risk: A systematic review. Int J Obes (Lond) 2009;34:18-28.
3. Park K, Steffes M, Lee DH, Himes JH, Jacobs DR. Association of inflammation with worsening HOMA-insulin resistance. Diabetologia 2009;52:2337-2344.
4. Roberts CK, Chen AK, Barnard RJ. Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 2007;191:98-106.
5. Kelishadi R, Hashemi M, Mohammadifard N, Asgary S, Khavarian N. Association of changes in oxidative and pro-inflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin Chem 2008;54:147-153.
6. Giannini C, de Giorgis T, Scarinci A, Marcovecchio ML, Chiarelli F, Mohn A. Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: The speculative role of insulin sensitivity, oxidant status, and chronic inflammation. Eur J Endocrinol 2009;161:73-80.
7. McGill HC, McMahan CA, Gidding SS. Are pediatricians responsible for prevention of adult cardiovascular disease? Nat Clin Pract Cardiovasc Med 2009;6:10-11.
8. Jain SK, Mc Vie R, Juramillo JJ, Palmer M, Smith T, Mea-chum ZD, Little RL. Effects of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 1996; 31:887-890.
9. Paolisso G, d'Amore A, Balbi V. Plasma vitamin C affects glucose homeostasis in healthy subjects and non-insulin dependent diabetics. Am J Physiol 1994;266:E261-E268.
10. \+\+ AT-Pase activity reduction in high glucose-treated human eryth-rocytes. Free Radic Biol Med 2000;29:1122-1128.
11. Song Y, Wang J, Li XK, Cai L. Zinc and the diabetic heart. Biometals 2005;18:325-332.
12. Partida-Hernández G, Arreola F, Fenton B, Cabeza M, Roman-Ramos R, Revilla-Monsalve MC. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 2006;60:161-168.
13. Islam MS, Loots du T. Diabetes, metallothionein, and zinc interactions: A review. Biofactors 2007;29:203-212.
14. Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: A double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud 2008;5:102-109.
15. Bonnefont-Rousselot D. The role of antioxidant micro-nutrients in the prevention of diabetic complications. Treat Endocrinol 2004;3:41-52.
16. Hashemipour M, Kelishadi R, Shapouri J, Sarrafzadegan N, Amini M, Tavakoli N, Movahedian-Attar A, Mirmoght-adaee P, Poursafa P. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens) 2009;8: 279-285.
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM. CDC growth charts: United States. Adv Data 2000;314:1-27.
18. Marshall WA, Tanner JM. Variations in the pattern of pu-bertal changes in girls. Arch Dis Child 1969;44:291-303.
19. National high blood pressure education program working group on high blood pressure in children and adolescents. The forth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576.
20. Esterbauer H, Cheeseman KH. Determination of aldehy-dic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
21. Marreiro DN, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Franciscato Cozzolino SM. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res 2006;112:109-118.
22. DiSilvestro RA. Zinc in relation to diabetes and oxidative stress. J Nutr 2000;130:1509S-1511S.
23. Moustafa SA. Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 2004;201:149-155.
24. Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood) 2001;226:103-111.
25. Adachi Y, Yoshikawa Y, Sakurai H. Antidiabetic zinc (II)-N-acetyl-L- cysteine complex: Evaluations of in vitro in-sulinomimetic and in vivo blood glucose-lowering activities. Biofactors 2007;29:213-223.
26. Karmaker S, Saha TK, Yoshikawa Y, Sakurai H.A Zinc(II)/poly(gamma- glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice. Macromol Biosci 2009;9:279-286.
27. Gómez-Garćia A, Hernández-Salazar E, González-Ortiz M, Martínez-Abundis E. Effect of oral zinc administration on insulin sensitivity, leptin and androgens in obese males. Rev Med Chil 2006;134:279-284.
28. Rashidi A, Razzaghy-Azar M, Garg ML, Mohammadpour B, Shariatzadeh N, Mohammad K, Kimiagar SM. Effects of zinc supplementation on metabolic control indices in children with type I diabetes. Hakim Res J 2004;6:26-29 [in Persian]
29. Thompson A, Danesh J. Associations between apolipopro-tein B, apolipoproteinAI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 2006;259:481-492.
30. Kelishadi R, Cook SR, Amra B, Adibi A. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis 2009;204:538-543.
31. Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract 2004;65: 21-28. (Pubitemid 38649045)
32. Kelishadi R, Alikhassy H, Amiri M. Zinc and copper status in children with high family risk of premature cardiovascular disease. Ann Saudi Med 2002;22:291-294